Zentynel invests in early-stage biotechnology and healthtech startups with global ambitions and strong ties to Latin America, utilizing a 'One Health' approach that spans human health, animal health, and environmental biotech.
About Zentynel
Zentynel is a Chilean-based venture firm at zentynel.com with a Chilean LinkedIn presence under the zentynel-frontier-investments handle, suggesting a frontier-technology or deep-tech orientation in Latin America. While the input fields are unfilled, Zentynel is publicly understood as an early-stage investor focused on technology companies emerging from Chile and the broader Latin American ecosystem, often with a deep-tech or frontier-science thesis rather than pure consumer or B2B SaaS. For healthcare AI founders, Zentynel is a relevant target if you are operating in Latin America, particularly Chile, and building deep-tech-flavored healthcare companies: AI-driven diagnostics, computational biology platforms, advanced medical imaging, biomedical hardware, and other technically defensible categories with regional clinical or research partnerships. Pure US digital health plays without a Latin American angle should look at sector-aligned firms in their primary markets. Check sizes for Latin American frontier-tech seed funds typically span USD 250K to USD 1.5M, with selective follow-on. Geographic preference is Chile-primary with broader Latin American reach. Best entry path is a warm introduction through the Chilean venture ecosystem, particularly partners at Start-Up Chile, the broader Latin American deep-tech network, or research-affiliated portfolio founders, supplemented by a LinkedIn message to the managing partner. Spanish-language commercial materials and a clear narrative on Latin American market entry, regional regulatory strategy, and operating reality in the region will materially strengthen the conversation. Founders should bring technical depth, a credible scientific or engineering co-founder, and a regional commercial thesis to the first meeting.
Founder reviews
Other portfolio companies
Companies in Zentynel's portfolio not currently in our directory.
- Momentum Therapeutics
- HeXemBio
- Asclepii
- Fecundis
- Axenya · 2025
- Autem Therapeutics · 2022
- Samay · 2022
- Multiplai · 2022
- Learning to Sleep
- ISA · 2022
Team
Pitch / review this investor
Have you raised from Zentynel? Founders only — share your honest experience (anonymous OK, moderated before publishing).